Background and Purpose-We compared the association of low estimated glomerular filtration rate (eGFR) with stroke outcomes among patients with hypertension and without hypertension. Methods-We used the China stroke registry to identify patients on discharge with the diagnosis of stroke in 2012 and 2013.
S troke has become the second cause of death (88 per 100 000 population) and the third cause of disabilityadjusted life years (15 per 1000 population) worldwide in 2010. 1, 2 Low estimated glomerular filtration rate (eGFR), 1 of 2 key renal measures for chronic kidney disease, is related to the risk of cardiovascular events in many studies. [3] [4] [5] Hypertension has been estimated to be responsible for at least 50% of deaths because of stroke 6 and is both a cause and consequence of chronic kidney disease. 7 However, there is little data evaluating the association of low eGFR with adverse outcomes in stroke patients with the presence or absence of hypertension. Thus, the goal of the current study was to use the China national stroke registry phase II to compare the association between low eGFR and stroke outcomes in hypertensive versus nonhypertensive patients.
Methods
The study population included patients who survived a stroke at discharge in China national stroke registry phase II. From June 2012 to January 2013, 21 075 patients were included in the final analysis after excluding patients because of missing eGFR value and loss to 1-year follow-up. (Figure 1 ; Table I in the online-only Data Supplement). Written informed consents were obtained from patients or their legally authorized representatives. The study was approved by the central institutional review board at Beijing Tiantan hospital.
eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration creatinine equation with adjusted
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June 2017 coefficient of 1.1 for the Asian population. 8, 9 eGFR values were stratified into 3 categories: <60, 60 to 89, and ≥90 mL/min/1.73 m 2 , which were based on the classification for chronic kidney disease assessment and management 10 but modified for the following reason: participants with moderate or severe renal insufficiency and kidney failure were pooled together into the category of eGFR <60 mL/min per 1.73 m 2 because of the small sample size. Low eGFR was defined as <60 mL/min/1.73 m 2 . Follow-up was performed by telephone interview at 12 months after disease onset. Outcome data collected contained allcause mortality, recurrent stroke, and poor functional outcome. Composite end points included all-cause mortality and recurrent stroke. Poor functional outcome was defined by modified Rankin Scale of 3 to 6 (mRS, score range from 0 [no symptoms] to 6 [death]). And mRS was also analyzed as an ordinal outcome with 6 categories in this study.
Differences of continuous variables between eGFR categories were tested with t test or Kruskal-Wallis test depending on if the data are normally distributed or not, respectively. The χ 2 test (or Fisher exact test with frequencies <5) was used for categorical variables. The association between eGFR strata and clinical outcomes was evaluated using a logistic or proportional odds regression model with eGFR of ≥90 mL/min/1.73 m 2 as the reference group adjusting for covariates among all patients stratified by hypertension status. We also tested the statistical significance of the interaction between eGFR category and hypertension in the adjusted model using all subjects.
Further information about study participants, data collection, and statistical analysis are available in the online-only Data Supplement.
Results
Of 5082 patients without hypertension, 221 patients (4.4%) had low eGFR and of 15 993 patients with hypertension, 1378 patients (8.6%) experienced low eGFR. The Table demonstrates baseline characteristics of nonhypertensive and hypertensive patients with stroke according to eGFR categories. Figure I and Table II in the online-only Data Supplement demonstrate 1-year incidences of stroke outcomes among nonhypertensive and hypertensive patients according to eGFR categories. Odds ratios with 95% confidence interval of eGFR levels for stroke outcomes according to hypertensive status were reported in Figure 2 . The significant interaction between eGFR categories and hypertension was only found for poor functional outcome (P=0.046) and ordinal mRS (P=0.002). We observe that among eGRF <60 mL/min/1.73 m 2 , there were slightly higher percent of subjects with mRS scores in the range of 3 to 6 in nonhypertension group than in hypertension group (Table II in the online-only Data Supplement).
Discussion
In this national cohort study of stroke, low eGFR was associated with all-cause mortality, the composite end point of all-cause mortality and recurrent stroke, poor functional outcome, and ordinal mRS in both patients without and with hypertension, whereas the association of low eGFR with recurrent stroke only existed in those with hypertension. The magnitude of associations of low eGFR with allcause mortality and composite end points in patients without hypertension were similar to those with hypertension, but associations for poor functional outcome and ordinal mRS in nonhypertensive patients were stronger than those in hypertensive patients. We did not observe the interaction of eGFR and hypertension for all stroke outcomes except for poor functional outcome and ordinal mRS. Our results were consistent with results of previous studies. 11, 12 Importantly, our data provide additional information on stroke disability in a national-level registry. 
Pneumonia, n (%) 368 ( BMI indicates body mass index; CHD, coronary heart disease; eGFR, estimated glomerular filtration rate; IQR, interquartile range; mRS, modified Rankin Scale; and NIHSS, National Institutes of Health Stroke Scale. Figure 2 . Adjusted odds ratios of estimated glomerular filtration rate (eGFR) levels for all-cause mortality, recurrent stroke, composite end point, and functional outcome among stroke patients with nonhypertension and hypertension. CI indicates confidence interval; HP, hypertension; and mRS, modified Rankin Scale. *P value for interaction between eGFR categories and hypertension.
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There were several limitations to this study that should be addressed. First, our cohort only comprised Chinese adult patients with stroke, and the results might not be generalizable to other races or ethnicities. Second, patients with lack of baseline serum creatinine and missing follow-up information were excluded, and our results may have been subject to selection bias, such as differences in the presence of coronary heart disease. Third, we were not able to control for the potentially nephroprotective effects of postdischarge antihypertensive medication use because of lack of information on patient adherence during the follow-up period.
Summary
Effect of low eGFR on all-cause mortality and recurrent stroke in patients without hypertension was not significantly different from that in those with hypertension, but low-eGFR patients without hypertension had a higher risk of stroke-related disability than those with hypertension.
